Increased plasma DPP4 activity is an independent predictor of the onset of metabolic syndrome in Chinese over 4 years: Result from the China national diabetes and metabolic disorders study

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Yang, Fan ^a,b   Zheng, Tianpeng ^a,b   Gao, Yun ^a   Baskota, Attit ^a   Chen, Tao ^a   Ran, Xingwu ^a   Tian, Haoming ^a  

^a SICHUAN UNIVERSITY   (China)

^b GUILIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; GLUCAGON LIKE PEPTIDE 1; DPP4 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHINESE; COHORT ANALYSIS; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; ONSET AGE; PROSPECTIVE STUDY; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; RISK FACTOR; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CHINA; DIABETES MELLITUS; ENZYMOLOGY; METABOLISM; MIDDLE AGED; ODDS RATIO; STATISTICAL MODEL;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; DIABETES MELLITUS; DIPEPTIDYL PEPTIDASE 4; FEMALE; GLUCAGON-LIKE PEPTIDE 1; HUMANS; LINEAR MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO;

EID: 84898617958     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092222     Document Type: Article

References (13)

1. von Bibra H, Sutton MSJ (2010) Diastolic dysfunction in diabetes and the metabolic syndrome: promising potential for diagnosis and prognosis. Diabetologia 53: 1033-1045.
2. Sattar N, McConnachie A, Shaper AG, Blauw GJ, Buckley BM, et al. (2008) Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. The Lancet 371: 1927-1935.
3. Wellen KE, Hotamisligil GS (2005) Inflammation, stress, and diabetes. Journal of Clinical Investigation 115: 1111-1119. (Pubitemid 40629025)
4. Sell H, Dietze-Schroeder D, Eckel J (2006) The adipocyte-myocyte axis in insulin resistance. Trends in Endocrinology & Metabolism 17: 416-422. (Pubitemid 44780130)
5. Matteucci E, Giampietro O (2009) Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme. Current medicinal chemistry 16: 2943-2951.
6. Lamers D, Famulla S, Wronkowitz N, Hartwig S, Lehr S, et al. (2011) Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes 60: 1917-1925.
7. Cordero OJ, Salgado FJ, Nogueira M (2009) On the origin of serum CD26 and its altered concentration in cancer patients. Cancer immunology, immunotherapy 58: 1723-1747.
8. Yang W, Lu J, Weng J, Jia W, Ji L, et al. (2010) Prevalence of diabetes among men and women in China. New England Journal of Medicine 362: 1090-1101.
9. Luepker R, Evans A, McKeigue P, Reddy K (2004) Cardiovascular Survey Methods World Health Organization. Geneva, Switzerland.
10. Kirino Y, Sei M, Kawazoe K, Minakuchi K, Sato Y (2011) Plasma dipeptidyl peptidase 4 activity correlates with body mass index and the plasma adiponectin concentration in healthy young people. Endocrine journal 59: 949-953.
11. Li L, El-Kholy W, Rhodes C, Brubaker P (2005) Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B. Diabetologia 48: 1339-1349. (Pubitemid 41186100)
12. Zhang J, Tokui Y, Yamagata K, Kozawa J, Sayama K, et al. (2007) Continuous stimulation of human glucagon-like peptide-1 (7-36) amide in a mouse model (NOD) delays onset of autoimmune type 1 diabetes. Diabetologia 50: 1900-1909. (Pubitemid 47222856)
13. Ørskov C, Wettergren A, Holst JJ (1993) Biological effects and metabolic rates of glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 in healthy subjects are indistinguishable. Diabetes 42: 658-661. (Pubitemid 23127154)